Mochida PharmaceuticalMochida Pharmaceutical Co.,Ltd.4534東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

What does Mochida Pharmaceutical do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

※ Operating cash flow is negative

Operating cash flow
-¥7.35B
Capex
¥2.69B
of revenue 2.3%
Free cash flow
-¥10B
Returned to shareholders
¥2.84B
of net income: 36%
Dividend per share
¥80
Payout ratio (reported)
43.3%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥7.9B
Operating cash flow-¥7.35B
Cash conversion (operating CF ÷ operating income)
-72.4%
Cash vs. profit gap
-¥15.3B(純利益の -193.0%)
Shareholder returns
of net income 35.9%
Shareholder payments — dividends
of net income 35.9%
CapEx intensity (capex ÷ revenue)
2.3%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow-¥7.35B
FY ending Mar 2022: ¥7.46B¥7.46BFY ending Mar 2023: ¥7.3B¥7.3BFY ending Mar 2024: -¥7.48B-¥7.48BFY ending Mar 2025: ¥9.35B¥9.35BFY ending Mar 2026: -¥7.35B-¥7.35BFY22FY23FY24FY25FY26
Free cash flow-¥10B
FY ending Mar 2022: ¥4.47B¥4.47BFY ending Mar 2023: ¥5.13B¥5.13BFY ending Mar 2024: -¥9.78B-¥9.78BFY ending Mar 2025: ¥7.19B¥7.19BFY ending Mar 2026: -¥10B-¥10BFY22FY23FY24FY25FY26
Net income¥7.9B
FY ending Mar 2022: ¥10.6B¥10.6BFY ending Mar 2023: ¥6.65B¥6.65BFY ending Mar 2024: ¥4.55B¥4.55BFY ending Mar 2025: ¥5.68B¥5.68BFY ending Mar 2026: ¥7.9B¥7.9BFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第88期(2025/04/01-2026/03/31)

    ID S100YI282026-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第87期(2024/04/01-2025/03/31)

    ID S100W7OB2025-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第86期(2023/04/01-2024/03/31)

    ID S100TRAN2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第85期(2022/04/01-2023/03/31)

    ID S100R7OO2023-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第84期(令和3年4月1日-令和4年3月31日)

    ID S100OI5J2022-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第83期(令和2年4月1日-令和3年3月31日)

    ID S100LOG52021-06-29Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.